Sympathetic hyperactivation, a common feature of obesity and metabolic syndrome, is a key trigger of hypertension. However, some obese subjects with autonomic unbalance present a dissociation between sympathetic activity mediated vasoconstriction and increased blood pressure. Here, we aimed to determine in a rat model of metabolic syndrome, whether the endothelium eNOS-NO pathway contribute to counteract the vasopressor effect of the sympathetic system.
Rats were fed a high fat and high sucrose diet for 15 weeks (HFS). Sympatho-vagal balance was evaluated by spectral analysis of heart rate variability and plasmatic catecholamines measurements. Blood pressure was measured in presence or not of L-NAME to inhibit the contribution of eNOS. Vascular reactivity was assessed on isolated aortic rings in response to α1-adrenergic agonist.
HFS diet increased sympathetic tone, which is characterized by higher low on high-frequency spectral power ratio and higher plasmatic concentration of epinephrine. Despite this, no change in blood pressure was observed. Interestingly, HFS rats exhibited vascular hyporeactivity (-23.6%) to α1-adrenergic receptors stimulation that was abolished by endothelial removing or eNOS inhibition (L-NAME). In addition, eNOS phosphorylation (ser1177) was increased in response to phenylephrine in HFS rats only. Accordingly, eNOS inhibition in-vivo revealed higher blood pressure in HFS compared to control rats (Respectively 147 vs 126 mmHg for mean blood pressure).
Restrain of adrenergic vasopressor action by the endothelium eNOS is increased in HFS rats and contributes to maintain blood pressure in physiological range.